SOURCE: Novartis

DESCRIPTION:

The Energize program is a collaboration between 10 global pharmaceutical companies, including Novartis, to engage hundreds of suppliers in bold climate action and decarbonization of the pharmaceutical value chain. The program is a first-of-its-kind effort to leverage the scale of a single industry’s global supply chain in a pre-competitive fashion to drive system level change. Creating life-saving medicines and services requires a lot of energy, much of it being used by the value chain. By proactively engaging with their suppliers to create renewable energy opportunities, the 10 convening companies are taking meaningful action to collectively address their energy usage and inspire other industry sectors to follow suit.

The program will help pharmaceutical and healthcare suppliers to address their own operational Scope 2 greenhouse gas emissions through green power procurement, which in turn will reduce the participating companies’ Scope 3 emissions. The program will be designed and delivered by Schneider Electric; the pharmaceutical companies will promote the program collectively, and individually invite their suppliers to participate.

Energize was announced on November 4, 2021 at COP26 in Glasgow. Read the press release: https://perspectives.se.com/sustainability/energize-program-for-pharma-suppliers

Pharmaceutical suppliers, other pharmaceutical, bioscience, and healthcare corporations, members of the media, and interested parties are welcome to join one of two introductory sessions to learn more about the program and how to participate:

• Tuesday, 9 November, 12:00 EST | 18:00 CET – Register Here
• Thursday, 11 November, 10:00 EST | 16:00 CET – Register Here

For more information, visit the Energize homepage at https://neonetworkexchange.com/energize

KEYWORDS: Novartis, NYSE: NVS